新股暗盤 | 美佳音控股(6939.HK)暗盤段漲3%
格隆匯3月30日丨據輝立證券,美佳音控股(6939.HK)現報1.3港元,較發行價1.26港元漲3.17%。公司是中國領先兼容打印機耗材芯片供應商之一,2017年至2019年收益分別為2.12億、2.46億、1.57億元人民幣,期間利潤分別為6313.5萬、6262萬、4131.3萬元人民幣,每股有形資產淨值0.65-0.7港元,2019歷史市盈率11.6-13.62倍。此次上市發售1.25億股,其中香港發售3750萬股,國際發售8750萬股,每手2000股,一手中籤率40%,香港發售股份獲22.43倍認購,淨籌1.014億港元,當中約51.4%將用作加強產品開發能力及產品多樣化。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.